Skip to NavigationSkip to content

Pharmafile - Research and Development News

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to research from Johns Hopkins...
The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall in the number of NHS GPs for more than...
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy Ellipta in the treatment of...
The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume the role...
Opioids to be labelled with addiction warning in UK Diabetes drug may help people quit smoking Scientists identify new form of dementia The price of...
Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently held by Brent...
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250...
A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials.
The FDA has said that Ambien must be labelled with a ‘black box warning’ – the most strongly worded warning issued by the FDA.
The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 years...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches